BIZ BUZZ: Unilab turns 80; new blood takes over
Given its consistent leadership in the pharmaceutical and health-care sectors, there are indeed many reasons for Campos Hess-led Unilab to go all out to celebrate its 80th anniversary.
But more than market dominance, what emerged as the highlight of the occasion is the leadership change at the homegrown pharmaceutical giant.
This year, Clinton Campos Hess takes over as chair of the Unilab Group, succeeding his mother, Jocelyn Campos Hess, who moves up as chair emeritus.
A graduate of the Wharton School of the University of Pennsylvania, Clinton has been the driving force of Unilab in its unprecedented growth while maintaining a low-key stance, not just in the pharmaceutical business with the various Unilab and RiteMed products, but even in animal health and health-care services through its Mount Grace chain of hospitals and clinics.
Lately, much has been heard about the conglomerate’s policy development also quietly spearheaded by Clinton through the Unilab Center for Health Policy, which is supporting the government in addressing systemic issues affecting the implementation of Universal Health Care.
With Clinton at the helm of the Unilab Group, there are also reports of the company venturing further afield into the education sector, signaling the robust leadership of the third-generation Campos scion.
This move reflects a commitment to innovation and growth, ensuring that Unilab continues to adapt and thrive in an ever-changing and increasingly competitive healthcare landscape.
